Alx Oncology Holdings (ALXO) Payables (2019 - 2026)

Alx Oncology Holdings has disclosed Payables across 8 years of filings, most recently posting $3.9 million for Q1 2026.

• Payables for Q1 2026 came in at $3.9 million, down 2.11% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.9 million (down 2.11% YoY), and the FY2025 annual result was $4.9 million, up 9.27% from the prior year.
• Payables came in at $3.9 million for Q1 2026 at Alx Oncology Holdings, down from $4.9 million in the prior quarter.
• In the past five years, Payables ranged from a high of $13.0 million in Q3 2023 to a low of $3.9 million in Q1 2026.
• The 5-year median for Payables is $6.2 million (2024), against an average of $6.7 million.
• Peak annual rise in Payables reached 121.11% in 2023, while the deepest fall reached 52.59% in 2023.
• Alx Oncology Holdings' Payables stood at $8.1 million in 2022, then rose by 6.42% to $8.6 million in 2023, then plunged by 47.65% to $4.5 million in 2024, then climbed by 9.27% to $4.9 million in 2025, then retreated by 21.57% to $3.9 million in 2026.
• The last three Payables figures came in at $3.9 million (Q1 2026), $4.9 million (Q4 2025), and $6.6 million (Q3 2025), per Business Quant data.